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BACKGROUND
Bronchopulmonary dysplasia (BPD) is 
characterized by chronic lung injury secondary to 
high levels of oxygen during the postnatal 
period. Properties of the preterm infant during 
the perinatal period, such as the presence and 
function of stem and progenitor cells, may 
interact with postnatal exposures such as 
hyperoxia. Alveolar macrophages derived from 
cord blood-derived (fetal) monocytes play a vital 
role in lung injury and repair. Previous studies 
have demonstrated administration of human 
cord blood (CB) monocytes results in decreased 
alveolar damage due to hyperoxia exposure but 
fail to demonstrate engraftment of these cells in 
the lung of the animal model. The MISTRG mice 
are IL2RG and Rag2 deficient while expressing 
human GM-CSF, IL-3/GM-CSF, TPO, and a 
SIRPa transgene, making it a useful model to 
study the effects of hyperoxia and human CB 
monocyte engraftment.
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Figure 4. Cell Engraftment in the Lung
HYPOTHESIS
Administration of human cord blood monocytes 
in MISTRG humanized mice ameliorate the BPD-
like phenotype after exposure to hyperoxia. 
METHODS
• Collected human cord blood from births at 
Prentice Women’s Hospital 
• Processed human CB within 36 hours of 
delivery
• Isolated monocytes and CD34+ cells by 
magnetic-activated cell sorting (MACS)
• Performed intra-hepatic injections of sorted 
monocytes, isolated CD34+ cells, and PBS 
(sham) at Day 0-1 of life
• Exposed pups to normoxia (21% oxygen) or 
hyperoxia (85% oxygen) for 7 days
• Harvested lungs and livers and performed 
H&E staining and immunohistochemistry for 
human CD45 
• Measured alveolar count and area in addition 




Intra-hepatic delivery of cord blood-derived 
monocytes leads to engraftment of human CD45+ 
cells in murine lungs, and may attenuate alveolar 
simplification due to hyperoxia. In the absence of 
CD34+ hematopoietic stem cells, the effects 
appear to be due to monocyte delivery from liver to 
lung, which is facilitated by human GM-CSF. 
Completion of the above studies, including 
quantification of engrafted human cells in the lungs 
and correlation with alveolar parameters, will 
demonstrate the extent to which CB monocytes 
may have a protective effect on neonatal lungs 
exposed to hyperoxia.
ACKNOWLEDGEMENTS
Special thanks to Dr. Karen Mestan and Rob Birkett for their 
mentorship, guidance, and support during this process.
BIBLIOGRAPHY
1. Abman SH, Ivy DD. Hospitalizations of Children With Pulmonary Hypertension: 
Implications for Improving Care. Pediatrics. 2015;136(2):392-3. 
2. Check J, Gotteiner N, Liu X, Su E, Porta N, Steinhorn R, et al. Fetal growth 
restriction and pulmonary hypertension in premature infants with 
bronchopulmonary dysplasia. J Perinatol. 2013. PMCID: PMC3633609 
3. del Cerro MJ, Sabate Rotes A, Carton A, Deiros L, Bret M, Cordeiro M, et al. 
Pulmonary hypertension in bronchopulmonary dysplasia: clinical findings, 
cardiovascular anomalies and outcomes. Pediatric pulmonology. 2014;49(1):49-
59. 
4. Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC, et al. 
Pulmonary artery hypertension in formerly premature infants with 
bronchopulmonary dysplasia: clinical features and outcomes in the surfactant 
era. Pediatrics. 2007;120(6):1260-9. 
5. Maxwell BG, Nies MK, Ajuba-Iwuji CC, Coulson JD, Romer LH. Trends in 
Hospitalization for Pediatric Pulmonary Hypertension. Pediatrics. 
2015;136(2):241-50.
6. Zupancic JA, Dukhovny D. Resource distribution in neonatology: beyond the 
Pareto principle. Archives of disease in childhood Fetal and neonatal edition. 
2015;100(6):F472-3. 
Ann & Robert H Lurie Children’s Hospital of Chicago/ Northwestern University Feinberg School of Medicine/ Neonatology
Figure 3. Cell Engraftment in the Liver
NEXT STEPS
1) Do the clinical characteristics of the patients 
(e.g., IUGR, chorioamnionitis, placental 
insufficiency) from which MNCs are derived 
influence engraftment and/or alveolar 
histology? 
2) Investigate changes in engraftment and 
alveolar histology with different MNC subsets 
(classical, intermediate, non-classical).
3) Interaction of intrauterine growth restriction 
(Thromboxane A2 analog) and hyperoxia on 
MNC engraftment.
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Figure 2. Conceptual Model 
The above established workflows 
consistently yield >10x106 monocytes 
per unit of cord blood. 
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